These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Crystal structure of a catalytic antibody with a serine protease active site. Zhou GW; Guo J; Huang W; Fletterick RJ; Scanlan TS Science; 1994 Aug; 265(5175):1059-64. PubMed ID: 8066444 [TBL] [Abstract][Full Text] [Related]
27. The preparation and crystallization of Fab fragments of a family of mouse esterolytic catalytic antibodies and their complexes with a transition-state analogue. Muranova TA; Ruzheinikov SN; Sedelnikova SE; Moir A; Partridge LJ; Kakinuma H; Takahashi N; Shimazaki K; Sun J; Nishi Y; Rice DW Acta Crystallogr D Biol Crystallogr; 2001 Aug; 57(Pt 8):1192-5. PubMed ID: 11468416 [TBL] [Abstract][Full Text] [Related]
28. Crystallographic and biochemical analysis of cocaine-degrading antibody 15A10. Larsen NA; de Prada P; Deng SX; Mittal A; Braskett M; Zhu X; Wilson IA; Landry DW Biochemistry; 2004 Jun; 43(25):8067-76. PubMed ID: 15209502 [TBL] [Abstract][Full Text] [Related]
29. A rat monoclonal antibody that catalyses the hydrolysis of a nitrophenyl-beta-lactam. Ostler EL; Dean CJ; Barber N; Valeri M; James S; Resmini M; Boucher G; Romanov N; Brocklehurst K; Gallacher G Biochem Biophys Res Commun; 2002 Nov; 299(2):273-6. PubMed ID: 12437982 [TBL] [Abstract][Full Text] [Related]
30. Three-dimensional structures of the Fab fragment of murine N1G9 antibody from the primary immune response and of its complex with (4-hydroxy-3-nitrophenyl)acetate. Mizutani R; Miura K; Nakayama T; Shimada I; Arata Y; Satow Y J Mol Biol; 1995 Nov; 254(2):208-22. PubMed ID: 7490744 [TBL] [Abstract][Full Text] [Related]
31. Structural basis of the broad substrate tolerance of the antibody 7B9-catalyzed hydrolysis of p-nitrobenzyl esters. Miyamoto N; Yoshimura M; Okubo Y; Suzuki-Nagata K; Tsumuraya T; Ito N; Fujii I Bioorg Med Chem; 2018 May; 26(8):1412-1417. PubMed ID: 29496413 [TBL] [Abstract][Full Text] [Related]
32. Site-directed mutagenesis of active site contact residues in a hydrolytic abzyme: evidence for an essential histidine involved in transition state stabilization. Miyashita H; Hara T; Tanimura R; Fukuyama S; Cagnon C; Kohara A; Fujii I J Mol Biol; 1997 Apr; 267(5):1247-57. PubMed ID: 9150409 [TBL] [Abstract][Full Text] [Related]
33. Molecular mechanism of enantioselective proton transfer to carbon in catalytic antibody 14D9. Zheng L; Baumann U; Reymond JL Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3387-92. PubMed ID: 14988504 [TBL] [Abstract][Full Text] [Related]
34. Efficient and selective p-nitrophenyl-ester-hydrolyzing antibodies elicited by a p-nitrobenzyl phosphonate hapten. Tawfik DS; Lindner AB; Chap R; Eshhar Z; Green BS Eur J Biochem; 1997 Mar; 244(2):619-26. PubMed ID: 9119032 [TBL] [Abstract][Full Text] [Related]
35. Probing the importance of second sphere residues in an esterolytic antibody by phage display. Arkin MR; Wells JA J Mol Biol; 1998 Dec; 284(4):1083-94. PubMed ID: 9837728 [TBL] [Abstract][Full Text] [Related]
36. Display of a functional hetero-oligomeric catalytic antibody on the yeast cell surface. Lin Y; Tsumuraya T; Wakabayashi T; Shiraga S; Fujii I; Kondo A; Ueda M Appl Microbiol Biotechnol; 2003 Aug; 62(2-3):226-32. PubMed ID: 12883868 [TBL] [Abstract][Full Text] [Related]
37. Directed evolution governed by controlling the molecular recognition between an abzyme and its haptenic transition-state analog. Takahashi-Ando N; Kakinuma H; Fujii I; Nishi Y J Immunol Methods; 2004 Nov; 294(1-2):1-14. PubMed ID: 15604011 [TBL] [Abstract][Full Text] [Related]
38. Evolution of shape complementarity and catalytic efficiency from a primordial antibody template. Xu J; Deng Q; Chen J; Houk KN; Bartek J; Hilvert D; Wilson IA Science; 1999 Dec; 286(5448):2345-8. PubMed ID: 10600746 [TBL] [Abstract][Full Text] [Related]
39. Mechanistically different catalytic antibodies obtained from immunization with a single transition-state analog. Guo J; Huang W; Zhou GW; Fletterick RJ; Scanlan TS Proc Natl Acad Sci U S A; 1995 Feb; 92(5):1694-8. PubMed ID: 7878042 [TBL] [Abstract][Full Text] [Related]
40. Analysis of hapten binding and catalytic determinants in a family of catalytic antibodies. Ulrich HD; Schultz PG J Mol Biol; 1998 Jan; 275(1):95-111. PubMed ID: 9451442 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]